Over the past decade, antiproliferative effects of somatostatin and analogs
have been reported in many somatostatin receptor-positive normal and tumor
cell types. Regarding the molecular mechanisms involved, somatostatin or a
nalogs mediate their action through both indirect and direct effects. Somat
ostatin acts through five somatostatin receptors (SSTR1-5) which are variab
ly expressed in normal and tumor cells. These receptors regulate a variety
of signal transduction pathways including inhibition of adenylate cyclase,
regulation of ion channels, regulation of serine/threonine and tyrosine kin
ases and phosphatases. This review focuses on recent advances in biological
mechanisms involved in the antineoplastic activity of somatostatin and ana
logs. Copyright (C) 2001 S. Karger AG, Basel.